BioAdvance Portfolio   Apply For Funding
BioAdvance provides funding to startup life sciences companies in Southeastern Pennsylvania through its
$20 million Greenhouse Fund. We invest in therapeutics, devices, diagnostics and platform technologies focused on human health.

Since our inception in 2002, BioAdvance has become one of the nation's leading investors providing
pre-seed and seed stage funding. To date we have committed more than $14 million to 24 seed-stage companies and 14 pre-seed stage companies. Our portfolio companies are working to develop products to treat health problems including Alzheimer's disease, cancer, obesity, GI disorders, neurological and respiratory illnesses. BioAdvance was established with $33 million from the Commonwealth of Pennsylvania's share of tobacco settlement monies.
Life